On October 27, 2023, the company announced an increase in its equity buyback plan. The company increased its authorization by CNY 100 million, thereby bringing its total authorization to CNY 300 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.91 CNY | -3.04% | +4.81% | -12.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.12% | 3.49B | |
+19.64% | 20.69B | |
0.00% | 18.4B | |
+6.07% | 11.56B | |
-10.06% | 9.69B | |
+17.79% | 7.66B | |
+14.08% | 6.19B | |
+2.13% | 4.62B | |
-15.27% | 3.91B | |
-4.59% | 3.69B |
- Stock Market
- Equities
- 300957 Stock
- News Yunnan Botanee Bio-Technology Group Co.LTD
- Yunnan Botanee Bio-Technology Group Co.LTD announces an Increase in Equity Buyback.